Peptonic Medical AB Postpones Publication of Interim Report for the Third Quarter
Cision•04/11/2026•02:30 ET
3
Key Highlights
- ➤Q3 2026 interim report publication postponed to November 26, 2026
- ➤Publication date moved from November 10 due to administrative reasons
Expert Statements
Daniel Rudeklint, Interim CEO of Peptonic Medical AB
“For further information, please contact:”
PEPTONIC Medical AB Peptonic Medical AB (publ) (the “Company”) announces a change to the publication date of its interim report for the third quarter of 2026. The publication date has been changed from November 10, 2026, to November 26, 2026. The postponement is due to administrative reasons.
Daniel Rudeklint, Interim CEO Peptonic Medical AB Email: daniel.rudeklint@peptonicmedical.se Phone: +46 73-158 02 73
Get started
Create a free account to read the full story.